fda warning letter hims compounded semaglutide september 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of RA/QA News Roll: Late September

176, E-138/A, Shastri Nagar opposite Metro Piller, New Delhi, Delhi 110065 Vendor Details Country of origin: India 750 MRP 773.443% off Save more with additional offers Get up to 75 cashback on a minimum order value (MOV) of 499 and above, valid once per customer

Brand: DH Nutrition

However, the subscription cannot be paused

According to the FDA's official guidance (updated April 2026 at fda.gov), the semaglutide injection shortage was resolved on February 21, 2025, and the transitional exemption windows for compounders operating under the shortage exemption subsequently ended - for 503A pharmacies by April 22, 2025, and for 503B outsourcing facilities by May 22, 2025

Understanding the Barrier to Receiving Weight Loss Injectables Our community members who are prescribed weight loss injectables containing the active ingredients semaglutide and tirzepatide have reported difficulties with consistently receiving their prescription

KPV enters cells through PepT1 and reduces inflammation via NF-B and MAP-kinase modulation [3]